Clinical Study
Predictors of Success of Different Treatment Modalities for Management of Ectopic Pregnancy
Table 1
Clinical parameters of rupture and nonrupture groups in EP.
| | | Group 1 () EP rupture (+) (SEM)1 | Group 2 () EP rupture (−) (SEM)1 | |
| | Age (years) | 31.46 0.74
| 30.18 ± 0.49 | 0.158 | | Gravidity | 2.94 ± 0.19 | 2.49 ± 0.13 | 0.060 | | Parity | 1.20 ± 0.12 | 0.93 ± 0.8 | 0.073 | | Hemoglobin (g/dL) | 10.53 ± 0.27 | 11.69 ± 0.12 | <0.01 | | Hematocrit (%) | 30.97 ± 0.80 | 34.67 ± 0.36 | <0.01 | | Platelet (109/L) | 264.31 ± 10.92 | 264.93 ± 6.09 | 0.961 | | White blood cell count (109/L) | 10.79 ± 0.48 | 9.05 ± 0.28 | 0.02 | | Neutrophil % | 73.07 ± 1.46 | 66.88 ± 0.99 | 0.01 | | Neutrophil count (109/L) | 7.94 ± 0.51 | 6.16 ± 0.24 | 0.02 | | βhCG2 (0 day) (mIU/mL) | | | | | <1000 (mIU/mL) | 10/56 (17.85%) | 46/56 (82.15%) | 0.02 | | 1000–3000 (mIU/mL) | 24/74 (32.43%) | 50/74 (67.57%) | | 3000–10000 (mIU/mL) | 17/39 (43.58%) | 22/39 (56.15%) | | >10000 (mIU/mL) | 16/28 (57.14%) | 12/28 (42.86%) | | Diameter of EP3 mass (mm) | 38.17 ± 1.83 | 25.44 ± 1.80 | <0.01 | | Endometrial thickness (mm) | 7.56 ± 0.45 | 6.58 ± 0.32 | 0.83 |
|
|
SEM: standard error of mean, 2βhCG: beta human chorionic gonadotropin, 3EP: ectopic pregnancy, statistical significance .
|
